Acquisitions in Russia

Sylvamo agreed to and completed the sale of all of its Russian operations to Pulp Invest Limited Liability Company for $420 million. After foreign currency exchange rates and transaction fees, Sylvamo received approximately $390 million in cash proceeds; Pulp Invest funded the transaction through bank financing as a management buyout vehicle.

Bonum Capital announced it is acquiring a 16% shareholding in PJSC Koks, Russia’s largest producer of merchant coke, purchasing the stake from a minority shareholder. The transaction value was not disclosed and is described as a financial (minority) investment, intended to support PJSC Koks’ expansion and provide greater certainty in its shareholder structure.

Acino completed the acquisition of a select portfolio of eight prescription pharmaceutical products and food supplements from the IlmixGroup group of companies in Russia. The portfolio spans gynaecology, gynaecologic oncology, urology, and dermatology, and includes brands such as Indinol Forto, Cervicon-DIM, Indinol, Epigallate, Promisan, and Indigal. As part of the deal, MiraxBioPharma (an IlmixGroup company) will continue manufacturing the products in Russia for Acino under manufacturing and supply agreements.